For her part, Mayda Mauri Pérez underscored the current moment and highlighted the solid alliance between the biopharmaceutical and health sectors as an essential pillar to sustain the supply of cancer drugs to the Cuban population, despite the intensification of the economic, commercial and financial blockade imposed by the United States.
The visit was also attended by medical oncologists, who exchanged criteria with the managers on therapeutic priorities, thus ensuring that the production responds directly to the clinical needs of patients.
The reactivation of this plant is not an isolated event: it is an eloquent example of how the Cuban biotechnology industry and the Public Health System work in total alliance, under the same objective: to guarantee the coverage of essential medicines at the most pressing time. In a country that faces externally induced shortages, each drug produced in this plant represents sovereignty, hope and commitment to the right to health of all Cubans.
SANGHA KOMMUNE (SSR) 